Bigora Sian — SEC Form 4 filings
SEC reporting owner CIK 1799365. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-19.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-04-12 to 2026-05-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 4 filings — 7,863 shares, $21,368 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: purchase of 1,799 shares @ $2.97 ($5,343) in Processa Pharmaceuticals, Inc., filed 2026-04-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | Chief Development Officer | 11 | 4 legs · 7,863 sh · $21,368 | — | 18 |
Form 4 filings — Bigora Sian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-19 | 4/A | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 1,971 @ $2.71 | EDGAR |
| 2026-05-01 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 1,986 @ $2.69 | EDGAR |
| 2026-04-17 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 1,799 @ $2.97 | EDGAR |
| 2026-04-01 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase (P): 2,107 @ $2.54 | EDGAR |
| 2026-02-04 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Option exercise (M): 249 @ $0 · Option exercise (M): 249 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 96,000 (derivative) @ $0 · Grant/award (A): 288,000 (derivative) @ $0 | EDGAR |
| 2025-09-18 | 4/A | Processa Pharmaceuticals, Inc. (PCSA) | Holdings only — no transactions reported | EDGAR |
| 2025-07-28 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/award (A): 1,659,185 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Option exercise (M): 15,059 · Tax withholding (F): 3,311 @ $0.41 | EDGAR |
| 2024-08-02 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Option exercise (M): 1,675 · Tax withholding (F): 368 @ $2.79 · Option exercise (M): 644 · Tax withholding (F): 225 @ $1.71 · Grant/award (A): 3,233 (derivative) @ $0 · Grant/award (A): 2,425 (derivative) @ $0 · +2 more | EDGAR |
| 2024-04-12 | 4 | Processa Pharmaceuticals, Inc. (PCSA) | Option exercise (M): 1,675 · Tax withholding (F): 368 @ $2.79 · Option exercise (M): 1,675 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1799365 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →